You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Claims for Patent: 10,772,829


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,772,829
Title:Aqueous ophthalmic solutions of phentolamine and medical uses thereof
Abstract:The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.
Inventor(s):Meyer Alan
Assignee:Ocuphire Pharma, Inc.
Application Number:US16398687
Patent Claims: 1. An aqueous ophthalmic solution , consisting of:a. about 0.1% (w/v) to about 4% (w/v) of phentolamine or a pharmaceutically acceptable salt thereof;b. about 1% (w/v) to about 6% (w/v) of at least one polyol compound selected from the group consisting of mannitol, glycerol, propylene glycol, ethylene glycol, sorbitol, and xylitol;c. about 0.1 mM to about 10 mM of at least one buffer;d. water; ande. optionally one or more of an alkali metal halide or alkaline earth metal halide;wherein the solution has a pH in the range of 4.0 to 7.5.2. The solution of claim 1 , wherein the solution has from about 0.25% (w/v) to about 2% (w/v) of phentolamine mesylate.3. The solution of claim 1 , wherein the solution has from about 0.25% (w/v) to about 1% (w/v) of phentolamine mesylate.4. The solution of claim 1 , wherein the solution has about 1% (w/v) of phentolamine mesylate.5. The solution of claim 1 , wherein the solution has about 4% (w/v) of the at least one polyol compound.6. The solution of claim 3 , wherein the solution has about 4% (w/v) of the at least one polyol compound.7. The solution of claim 4 , wherein the solution has about 4% (w/v) of the at least one polyol compound.8. The solution of claim 1 , wherein the at least one polyol compound is mannitol.9. The solution of claim 4 , wherein the at least one polyol compound is mannitol.10. The solution of claim 7 , wherein the at least one polyol compound is mannitol.11. The solution of claim 1 , wherein the buffer is present at a concentration in the range of about 2 mM to about 4 mM.12. The solution of claim 4 , wherein the buffer is present at a concentration in the range of about 2 mM to about 4 mM.13. The solution of claim 7 , wherein the buffer is present at a concentration in the range of about 2 mM to about 4 mM.14. The solution of claim 10 , wherein the buffer is present at a concentration in the range of about 2 mM to about 4 mM.15. The solution of claim 1 , wherein the buffer is present at a concentration of about 3 mM.16. The solution of claim 4 , wherein the buffer is present at a concentration of about 3 mM.17. The solution of claim 7 , wherein the buffer is present at a concentration of about 3 mM.18. The solution of claim 10 , wherein the buffer is present at a concentration of about 3 mM.19. The solution of claim 1 , wherein the buffer comprises an alkali metal acetate.20. The solution of claim 4 , wherein the buffer comprises an alkali metal acetate.21. The solution of claim 7 , wherein the buffer comprises an alkali metal acetate.22. The solution of claim 10 , wherein the buffer comprises an alkali metal acetate.23. The solution of claim 18 , wherein the buffer comprises an alkali metal acetate.24. The solution of claim 1 , wherein the buffer comprises sodium acetate.25. The solution of claim 4 , wherein the buffer comprises sodium acetate.26. The solution of claim 7 , wherein the buffer comprises sodium acetate.27. The solution of claim 10 , wherein the buffer comprises sodium acetate.28. The solution of claim 18 , wherein the buffer comprises sodium acetate.29. The solution of claim 1 , wherein the solution has a pH in the range of 4.5 to 5.5.30. The solution of claim 4 , wherein the solution has a pH in the range of 4.5 to 5.5.31. The solution of claim 7 , wherein the solution has a pH in the range of 4.5 to 5.5.32. The solution of claim 10 , wherein the solution has a pH in the range of 4.5 to 5.5.33. The solution of claim 18 , wherein the solution has a pH in the range of 4.5 to 5.5.34. The solution of claim 23 , wherein the solution has a pH in the range of 4.5 to 5.5.35. The solution of claim 28 , wherein the solution has a pH in the range of 4.5 to 5.5.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.